Potential therapeutic response in a severe case of autosomal dominant osteopetrosis type I

Autor: Syed Maisam Jafri, Elizabeth A. Burke, David R. Adams, Colleen Evans, Dorothy Bulas, Stuart A. Weinerman, Kristen Pan, Michael T. Collins, Thomas C. Markello, Gilbert Vezina, William A. Gahl, Camilo Toro
Rok vydání: 2022
Zdroj: Journal of Translational Genetics and Genomics. 6:281-289
ISSN: 2578-5281
DOI: 10.20517/jtgg.2021.63
Popis: The low-density lipoprotein receptor-related protein 5 gene (LRP5), which encodes a coreceptor within the canonical Wnt signaling pathway, plays a crucial role in bone mass regulation and has been associated with several bone disorders. Autosomal dominant osteopetrosis type I (ADO type I, OMIM 607634) is a rare disease caused by heterozygous, gain-of-function mutations in LRP5. Here we describe a 44-year-old female who presented with thickened calvarium, elevated bone density, torus palatinus, mandibular exostoses, enlarged mandible, and disabling headaches and bone pain. Exome sequencing revealed a previously reported heterozygous missense variant in the LRP5 gene (p.A242T). Post-diagnosis cranial vault volume measurement by computed tomography 3D reconstruction demonstrated decreasing intracranial volume over time. Off-label use of leuprolide acetate was associated with apparent stabilization of skull mineralization. This report documents a severe example of ADO type I and provides anecdotal evidence of the utility of therapy in need of formal evaluation.
Databáze: OpenAIRE